Latest Articles

Publication Date
Exosomal miR-22-3p targets p53 to regulate endometrial epithelial cell function in the pathogenesis of endometriosis.

Endometriosis (EMs) is a widespread gynecological disease, affecting approximately 6-10% of females of child-bearing age. Despite its significant influence on women's health, the specific pathophysiology remains unclear. The enrichment of …

Published: Sept. 4, 2026, midnight
Long non-coding RNAs in female infertility: Advancing from molecular insights to clinical relevance.

A broad range of genetic and epigenetic factors contributes to female infertility, a substantial proportion of which is related to ovulatory disorders. Any factor that disrupts the normal function of …

Published: Aug. 31, 2026, midnight
Cancer care is becoming personal: How biomarker testing is changing treatment decisions - theweek.in

Cancer care is becoming personal: How biomarker testing is changing treatment decisions theweek.in

Published: Aug. 28, 2026, 7:11 a.m.
Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer - CancerNetwork

Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer CancerNetwork

Published: Aug. 26, 2026, 8:08 p.m.
What Are Biomarkers And How Are They Transforming Women’s Health? - TechRound

What Are Biomarkers And How Are They Transforming Women’s Health? TechRound

Published: Aug. 24, 2026, 2:49 p.m.
Study on the role of miR-433-3p in the occurrence and development of endometriosis.

This study aims to characterize the expression pattern and biological functions of miR-433-3p in endometriosis. Eutopic and ectopic endometrial tissues were collected from endometriosis patients, and the expression level of …

Published: Aug. 21, 2026, midnight
Exploring the exercise dose to induce symptomatic and biomarker change in endometriosis: A protocol for a randomised controlled trial.

Exercise may be an effective tool to improve symptoms and quality of life in those with endometriosis. However, the optimal dose to elicit such changes is unknown. This study will …

Published: Aug. 19, 2026, midnight
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - AllSci

Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer AllSci

Published: Aug. 18, 2026, 2:27 p.m.
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - allsci.com

Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer allsci.com

Published: Aug. 18, 2026, 2:27 p.m.
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer BioSpace

Published: Aug. 17, 2026, 1:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!